» Articles » PMID: 37374303

Predicting Post-Hepatectomy Liver Failure in HCC Patients: A Review of Liver Function Assessment Based on Laboratory Tests Scores

Overview
Publisher MDPI
Specialty General Medicine
Date 2023 Jun 28
PMID 37374303
Authors
Affiliations
Soon will be listed here.
Abstract

The assessment of liver function is crucial in predicting the risk of post-hepatectomy liver failure (PHLF) in patients undergoing liver resection, especially in cases of hepatocellular carcinoma (HCC) which is often associated with cirrhosis. There are currently no standardized criteria for predicting the risk of PHLF. Blood tests are often the first- and least invasive expensive method for assessing hepatic function. The Child-Pugh score (CP score) and the Model for End Stage Liver Disease (MELD) score are widely used tools for predicting PHLF, but they have some limitations. The CP score does not consider renal function, and the evaluation of ascites and encephalopathy is subjective. The MELD score can accurately predict outcomes in cirrhotic patients, but its predictive capabilities diminish in non-cirrhotic patients. The albumin-bilirubin score (ALBI) is based on serum bilirubin and albumin levels and allows the most accurate prediction of PHLF for HCC patients. However, this score does not consider liver cirrhosis or portal hypertension. To overcome this limitation, researchers suggest combining the ALBI score with platelet count, a surrogate marker of portal hypertension, into the platelet-albumin-bilirubin (PALBI) grade. Non-invasive markers of fibrosis, such as FIB-4 and APRI, are also available for predicting PHLF but they focus only on cirrhosis related aspects and are potentially incomplete in assessing the global liver function. To improve the predictive power of the PHLF of these models, it has been proposed to combine them into a new score, such as the ALBI-APRI score. In conclusion, blood test scores may be combined to achieve a better predictive value of PHLF. However, even if combined, they may not be sufficient to evaluate liver function and to predict PHLF; thus, the inclusion of dynamic and imaging tests such as liver volumetry and ICG r15 may be helpful to potentially improve the predictive capacity of these models.

Citing Articles

Predicting post-hepatectomy liver failure using a nomogram based on portal vein width, inflammatory indices, and the albumin-bilirubin score.

Sun K, Li J, Chen Y, Zhai Z, Chen L, Dong R World J Gastrointest Surg. 2025; 17(2):99529.

PMID: 40061983 PMC: 11886008. DOI: 10.4240/wjgs.v17.i2.99529.


Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents.

Zhang Y, Xia H, Fan L, Jiang L, Yang B, Wang F Infect Drug Resist. 2025; 18:455-471.

PMID: 39877380 PMC: 11774102. DOI: 10.2147/IDR.S487414.


Hepatobiliary scintigraphy and liver function changes in patients with hepatocellular carcinoma treated with Ho-radioembolization : HBS in HCC treated with holmium-166.

Reinders M, Smits M, van Erpecum K, de Bruijne J, Bruijnen R, Sprengers D EJNMMI Res. 2025; 15(1):2.

PMID: 39786516 PMC: 11717772. DOI: 10.1186/s13550-025-01196-9.


Predictors of Post-Hepatectomy Liver Failure in Klatskin Tumors: The Role of Preoperative Glucose, Future Liver Remnant to Spleen Ratio, and Early Bilirubin Monitoring.

Kim S, Ku H, Moon H, Song S, Choi Y, Shin D Diagnostics (Basel). 2024; 14(23).

PMID: 39682624 PMC: 11640423. DOI: 10.3390/diagnostics14232716.


Dynamic [Tc]Tc-mebrofenin SPECT/CT in preoperative planning of liver resection: a prospective study.

Bakos A, Libor L, Urban S, Geczi T, Bukva M, Hohn J Sci Rep. 2024; 14(1):30305.

PMID: 39638819 PMC: 11621425. DOI: 10.1038/s41598-024-81331-z.


References
1.
Mullen J, Ribero D, Reddy S, Donadon M, Zorzi D, Gautam S . Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007; 204(5):854-62. DOI: 10.1016/j.jamcollsurg.2006.12.032. View

2.
Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A . A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection. Surgery. 2015; 157(4):699-707. DOI: 10.1016/j.surg.2014.10.022. View

3.
Mai R, Ye J, Long Z, Shi X, Bai T, Chen J . Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res. 2019; 11:1401-1414. PMC: 6388945. DOI: 10.2147/CMAR.S186114. View

4.
Hiraoka A, Kumada T, Tsuji K, Takaguchi K, Itobayashi E, Kariyama K . Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis. Liver Cancer. 2019; 8(2):121-129. PMC: 6465715. DOI: 10.1159/000488778. View

5.
Farges O, Malassagne B, Flejou J, Balzan S, Sauvanet A, Belghiti J . Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999; 229(2):210-5. PMC: 1191633. DOI: 10.1097/00000658-199902000-00008. View